These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1105872)

  • 1. The effect of Dopaflex and Viregyt-K on gait and postural disturbances of operated and non-operated Parkinsonian patients.
    Boczán G; Borus F; Rózsa L
    Ther Hung; 1975; 23(1):17-20. PubMed ID: 1105872
    [No Abstract]   [Full Text] [Related]  

  • 2. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)].
    Shiozawa R; Kase M; Kuroiwa Y; Narabayashi H; Nishitani Y; Ohmoto T; Toyokura Y; Uono K
    No To Shinkei; 1981 Mar; 33(3):301-9. PubMed ID: 7018522
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and electromyographic examinations on the effect of hydrochloride (Viregyt-K) in the treatment of Parkinson's disease.
    Schubert U; Fischer GJ; Glass J
    Ther Hung; 1977; 25(2):55-63. PubMed ID: 898119
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of dopaflex on the clinical picture and reaction time of parkinsonian patients.
    Antal J
    Ther Hung; 1974; 22(2):70-8. PubMed ID: 4419534
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
    Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
    Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study on Parkopan, Amantadine and L-dopa in the treatment of Parkinson's disease].
    Dzudza M; Dzudza D
    Med Arh; 1974; 28(4):407-15. PubMed ID: 4613968
    [No Abstract]   [Full Text] [Related]  

  • 7. [Modification of Parkinson tremor by budipine. A comparative study with amantadine].
    Iizuka J; Fischer R
    Nervenarzt; 1986 Mar; 57(3):184-6. PubMed ID: 3515215
    [No Abstract]   [Full Text] [Related]  

  • 8. Is parkinsonian gait caused by a regression to an immature walking pattern?
    Forssberg H; Johnels B; Steg G
    Adv Neurol; 1984; 40():375-9. PubMed ID: 6695614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual manifestations of Parkinson's disease after ten or more years of levodopa.
    Klawans HL
    Mov Disord; 1986; 1(3):187-92. PubMed ID: 3504244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new method of quantitative analysis of parkinsonian gait: report of 6 patients].
    Blin O; Ferrandez AM; Pailhous J; Serratrice G
    Rev Neurol (Paris); 1990; 146(1):48-50. PubMed ID: 2309059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative value of amantadine and levodopa.
    Dallos V; Heathfield K; Stone P; Allen F
    Postgrad Med J; 1972 Jun; 48(560):354-8. PubMed ID: 4558895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinsonism as a falling sickness.
    Klawans HL; Topel JL
    JAMA; 1974 Dec; 230(11):1555-7. PubMed ID: 4479664
    [No Abstract]   [Full Text] [Related]  

  • 13. Amantadine in Parkinsonism. An extended prospective trial.
    Rao NS; Pearce J
    Practitioner; 1971 Feb; 206(232):241-5. PubMed ID: 4928964
    [No Abstract]   [Full Text] [Related]  

  • 14. [Psychological changes in parkinsonian patients during L-DOPA, amantidine, and L-DOPA + IDC treatment (author's transl)].
    Puca FM; Megna GF; Masi G; Specchio LM
    Riv Patol Nerv Ment; 1974 Oct; 95(5):676-84. PubMed ID: 4470268
    [No Abstract]   [Full Text] [Related]  

  • 15. [A family of parkinsonism in which the clinical feature of constituents varied with the age of onset].
    Sasaki R; Kuzuhara S; Taniguchi A; Narita Y; Naito Y
    Rinsho Shinkeigaku; 1994 Jul; 34(7):736-8. PubMed ID: 7955737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of Parkinson's syndrome].
    Fortschr Med; 1982 Jun; 100(24):1172. PubMed ID: 7106681
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of amantadine (Viregyt-K) on extrapyramidal symptoms of parkinsonian patients.
    Boczán G
    Ther Hung; 1974; 22(4):147-53. PubMed ID: 4465958
    [No Abstract]   [Full Text] [Related]  

  • 18. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.
    O'Sullivan JD; Said CM; Dillon LC; Hoffman M; Hughes AJ
    Mov Disord; 1998 Nov; 13(6):900-6. PubMed ID: 9827613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of amantadine sulfate as a infusion solution in the treatment of parkinsonian syndrome].
    Muschard F; Völler GW
    Med Welt; 1973 Feb; 24(5):183-4. PubMed ID: 4617092
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
    Goberman AM
    Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.